BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:34 PM
 | 
Mar 23, 2009
 |  BC Extra  |  Top Story

Lilly's arzoxifene meets Phase III endpoints

Eli Lilly (NYSE:LLY) said its arzoxifene was superior to Evista raloxifene in the double-blind, international Phase III NEXT...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >